durvalumab
astrazeneca
topaz-1 exploratory analysis suggests that adding durvalumab to gemcitabine plus cisplatin improves advanced biliary tract cancer outcomes irrespective of the primary tumour site
#cholangiocarcinoma
#bileductcancer #biliarytractcancer #cholangiotwitter 
#LiverTwitter #CholangioTwitter  #BileDuctCancer breaking news.  Stage III T3 N0 Mx #intrahepatic #cholangiocarcinoma, NED since 05/29/2020! Word nerd ??